ELEKTA Stock Price, News & Analysis (OTCMKTS:EKTAY)

$8.74 0.14 (1.63 %)
(As of 01/21/2018 09:44 AM ET)
Previous Close$8.74
Today's Range$8.68 - $8.78
52-Week Range$7.85 - $11.18
Volume18,500 shs
Average Volume11,892 shs
Market Capitalization$3.22 billion
P/E Ratio174.80
Dividend Yield0.69%
Beta0.48

About ELEKTA (OTCMKTS:EKTAY)

ELEKTA logoElekta AB (publ) develops and sells clinical solutions for the treatment of cancer and brain disorders worldwide. The company offers Leksell Gamma Knife, a system for cranial stereotactic radiosurgery; the Extend system for utilization of Leksell Gamma Knife Perfexion; and Leksell Stereotactic System for neurosurgery and biopsies. Its neuroscience solutions comprise Gamma Knife radiosurgery for the treatment of brain disorders; stereotactic neurosurgery; and surgical navigation accessories, as well as Elekta Neuromag TRIUX, a magnetoencephalography platform. The company also provides oncology treatment solutions, such as Precise Treatment System, a digital treatment system; Elekta Axesse, a stereotactic radiation therapy system; Elekta Compact, a gateway to RT for oncology centers; Elekta Synergy system that visualizes tumor targets and normal tissue, and their movement between and during fractions; treatment planning systems; oncology information systems solutions; Versa HD, a linear accelerator; and Elekta Infinity system for volumetric arc modulated therapy, as well as various treatment techniques. In addition, it offers brachytherapy solutions that include afterloading platforms; real-time prostate solutions; Oncentra Brachy, a radiotherapy treatment planning system; Esteya for treating skin cancer; and applicators. Further, the company provides software products, including MOSAIQ oncology information system; Oncology Informatics/Data Alliances that streamlines the flow of information in the cancer care team; medical oncology software; Clarity Soft Tissue Visualization, a software for radiation therapy; Monaco, a treatment planning system; Venezia, an applicator for treating gynecological cancer; and METRIQ, a cancer registry data solution. It also offers installation, implementation, training, education, and consultative services. It primarily serves hospitals and academic institutions. The company was founded in 1972 and is headquartered in Stockholm, Sweden.

Receive EKTAY News and Ratings via Email

Sign-up to receive the latest news and ratings for EKTAY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:EKTAY
CUSIPN/A
Phone46-8-587-254-00

Debt

Debt-to-Equity Ratio0.71%
Current Ratio1.30%
Quick Ratio1.16%

Price-To-Earnings

Trailing P/E Ratio174.8
Forward P/E Ratio25.71
P/E Growth1.35

Sales & Book Value

Annual Sales$1.23 billion
Price / Sales2.63
Cash Flow$0.24 per share
Price / Cash36.05
Book Value$2.10 per share
Price / Book4.16

Profitability

Trailing EPS$0.04
Net Income$14.30 million
Net Margins1.71%
Return on Equity3.40%
Return on Assets1.11%

Miscellaneous

Employees3,681
Outstanding Shares368,590,000

ELEKTA (OTCMKTS:EKTAY) Frequently Asked Questions

What is ELEKTA's stock symbol?

ELEKTA trades on the OTCMKTS under the ticker symbol "EKTAY."

How often does ELEKTA pay dividends? What is the dividend yield for ELEKTA?

ELEKTA declared a None dividend on Thursday, July 20th. Stockholders of record on Friday, August 25th will be paid a dividend of $0.04 per share on Thursday, September 14th. The ex-dividend date is Wednesday, August 23rd. View ELEKTA's Dividend History.

How were ELEKTA's earnings last quarter?

ELEKTA (OTCMKTS:EKTAY) posted its quarterly earnings data on Wednesday, December, 4th. The company reported $0.07 EPS for the quarter. ELEKTA had a return on equity of 3.40% and a net margin of 1.71%. View ELEKTA's Earnings History.

When will ELEKTA make its next earnings announcement?

ELEKTA is scheduled to release their next quarterly earnings announcement on Thursday, January, 25th 2018. View Earnings Estimates for ELEKTA.

Who are some of ELEKTA's key competitors?

How do I buy ELEKTA stock?

Shares of ELEKTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ELEKTA's stock price today?

One share of ELEKTA stock can currently be purchased for approximately $8.74.

How big of a company is ELEKTA?

ELEKTA has a market capitalization of $3.22 billion and generates $1.23 billion in revenue each year. The company earns $14.30 million in net income (profit) each year or $0.04 on an earnings per share basis. ELEKTA employs 3,681 workers across the globe.

How can I contact ELEKTA?

ELEKTA's mailing address is P.O. Box 7593, Stockholm V7, SE-103 93. The company can be reached via phone at 46-8-587-254-00 or via email at [email protected]


MarketBeat Community Rating for ELEKTA (EKTAY)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  58 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  151
MarketBeat's community ratings are surveys of what our community members think about ELEKTA and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

ELEKTA (OTCMKTS:EKTAY) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldSellSell
Consensus Rating Score: 2.002.001.001.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

ELEKTA (OTCMKTS:EKTAY) Consensus Price Target History

Price Target History for ELEKTA (OTCMKTS:EKTAY)

ELEKTA (OTCMKTS:EKTAY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
11/13/2017JPMorgan Chase & Co.DowngradeOverweight -> NeutralView Rating Details
12/7/2016Jefferies GroupDowngradeHold -> UnderperformView Rating Details
(Data available from 1/21/2016 forward)

Earnings

ELEKTA (OTCMKTS:EKTAY) Earnings History and Estimates Chart

Earnings by Quarter for ELEKTA (OTCMKTS:EKTAY)

ELEKTA (OTCMKTS EKTAY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/25/2018        
6/1/2017Q4 2017$0.03ViewN/AView Earnings Details
3/1/2017Q4$0.02$295.66 millionViewListenView Earnings Details
12/1/2016Q2 2017$0.02ViewN/AView Earnings Details
9/1/2016Q1 2017($0.02)ViewN/AView Earnings Details
8/11/2016Q4 2016$0.02ViewN/AView Earnings Details
3/2/2016Q3 2016$0.03ViewN/AView Earnings Details
12/4/2015Q2 2016$0.06ViewN/AView Earnings Details
9/1/2015Q1 2016($0.03)ViewN/AView Earnings Details
6/2/2015Q4 2015$0.11ViewN/AView Earnings Details
3/4/2015Q3 2015$0.05ViewN/AView Earnings Details
11/27/2014Q2 2015$0.07ViewN/AView Earnings Details
8/28/2014Q1 2015($0.05)ViewN/AView Earnings Details
8/7/2014Q4 2014$0.31ViewN/AView Earnings Details
2/27/2014Q3 2014$0.06ViewN/AView Earnings Details
12/4/2013Q3$0.07ViewN/AView Earnings Details
9/3/2013Q1 2014$0.01ViewN/AView Earnings Details
6/5/2013Q4 2013$0.34ViewN/AView Earnings Details
3/5/2013Q3 2013$0.09ViewN/AView Earnings Details
12/4/2012Q2 2013$0.10ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

ELEKTA (OTCMKTS:EKTAY) Earnings Estimates

Current Year EPS Consensus Estimate: $0.34 EPS
Next Year EPS Consensus Estimate: $0.44 EPS

Dividends

ELEKTA (OTCMKTS:EKTAY) Dividend Information

Most Recent Dividend:9/14/2017
Annual Dividend:$0.06
Dividend Yield:0.69%
Payout Ratio:150.04% (Trailing 12 Months of Earnings)
17.65% (Based on This Year's Estimates)
13.64% (Based on Next Year's Estimates)
Dividend Payments by Quarter for ELEKTA (OTCMKTS:EKTAY)

ELEKTA (OTCMKTS:EKTAY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/20/2017None$0.048/23/20178/25/20179/14/2017
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for ELEKTA (OTCMKTS EKTAY)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

ELEKTA (OTCMKTS EKTAY) News Headlines

Source:
DateHeadline
ETFs with exposure to Elekta AB : December 18, 2017ETFs with exposure to Elekta AB : December 18, 2017
finance.yahoo.com - December 18 at 4:57 PM
Varian Gains Ground on New Applications, Grows in AustraliaVarian Gains Ground on New Applications, Grows in Australia
finance.yahoo.com - December 18 at 10:13 AM
Elekta Collaborates with Palabra to offer the Industrys Only Voice-enabled EHRElekta Collaborates with Palabra to offer the Industry's Only Voice-enabled EHR
finance.yahoo.com - December 15 at 10:22 AM
Elekta Chooses Brainlab as Exclusive Distributor in the U.S. for Stereotactic Neurosurgery SolutionsElekta Chooses Brainlab as Exclusive Distributor in the U.S. for Stereotactic Neurosurgery Solutions
finance.yahoo.com - December 13 at 10:13 AM
ETFs with exposure to Elekta AB : December 7, 2017ETFs with exposure to Elekta AB : December 7, 2017
finance.yahoo.com - December 7 at 5:20 PM
Elekta AB :EKTAY-US: Earnings Analysis: Q2, 2018 By the Numbers : December 5, 2017Elekta AB :EKTAY-US: Earnings Analysis: Q2, 2018 By the Numbers : December 5, 2017
finance.yahoo.com - December 5 at 10:36 AM
Elekta Introduces New Commercial Name for MEG Business and Reveals New System for Studying Brain Activity at 2017 American Epilepsy Society MeetingElekta Introduces New Commercial Name for MEG Business and Reveals New System for Studying Brain Activity at 2017 American Epilepsy Society Meeting
finance.yahoo.com - December 1 at 5:12 PM
Elekta delays order target for new radiation therapy machineElekta delays order target for new radiation therapy machine
finance.yahoo.com - November 30 at 10:23 AM
UKs National Health Service Signs GBP 22 Million Agreement for Elekta Cancer Treatment SystemsUK's National Health Service Signs GBP 22 Million Agreement for Elekta Cancer Treatment Systems
finance.yahoo.com - November 29 at 10:00 AM
Elekta AB (EKTAY) Lowered to Neutral at J P Morgan Chase & CoElekta AB (EKTAY) Lowered to Neutral at J P Morgan Chase & Co
www.americanbankingnews.com - November 26 at 11:56 PM
21st Century Oncology Chooses Elekta for Replacement of Radiation Therapy Devices21st Century Oncology Chooses Elekta for Replacement of Radiation Therapy Devices
finance.yahoo.com - November 21 at 5:05 AM
Romanian Government Signs Deal for Five Elekta Linear AcceleratorsRomanian Government Signs Deal for Five Elekta Linear Accelerators
finance.yahoo.com - November 17 at 12:36 PM
Elekta Monaco Users Win Top-ranking in Global Contest for SBRT Lung PlansElekta Monaco Users Win Top-ranking in Global Contest for SBRT Lung Plans
finance.yahoo.com - November 16 at 1:50 PM
Radiation Oncology Centres Launches Australia’s First Electronic Brachytherapy System for Treating Skin Cancer: Esteya by ElektaRadiation Oncology Centres Launches Australia’s First Electronic Brachytherapy System for Treating Skin Cancer: Esteya by Elekta
au.finance.yahoo.com - December 15 at 5:31 PM
European shares retreat from 3-week high; oil shares in demandEuropean shares retreat from 3-week high; oil shares in demand
uk.finance.yahoo.com - December 1 at 5:13 AM
Elekta: Doctors in Japan Begin Treating Patients with Elekta’s Leksell Gamma Knife IconElekta: Doctors in Japan Begin Treating Patients with Elekta’s Leksell Gamma Knife Icon
au.finance.yahoo.com - November 29 at 5:33 PM
All India Institute of Medical Science expands cancer care with advanced treatment devices from ElektaAll India Institute of Medical Science expands cancer care with advanced treatment devices from Elekta
au.finance.yahoo.com - October 18 at 9:46 AM
European shares boosted by rally in banks, minersEuropean shares boosted by rally in banks, miners
uk.finance.yahoo.com - September 1 at 7:52 AM
European shares led down by Swedens ElektaEuropean shares led down by Sweden's Elekta
uk.finance.yahoo.com - June 1 at 3:13 AM

SEC Filings

ELEKTA (OTCMKTS:EKTAY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

ELEKTA (OTCMKTS EKTAY) Stock Chart for Sunday, January, 21, 2018

Loading chart…

This page was last updated on 1/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.